Who owns AEROVATE THERAPEUTICS INC?
- Ticker: AVTE
- CUSIP Number: 008064107
Tip: Access positions for across all investors
Analyze quarterly positions in Aerovate Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv

Top investors of Aerovate Therapeutics stock
Who bought or sold AEROVATE THERAPEUTICS INC this quarter?
Fund or Company Name |
Shares Held |
Valued At |
Change in Shares |
As Of |
Actions |
---|---|---|---|---|---|
RA Capital Management | 9.2M | $24M | 0% | Dec 2024 |
|
Sofinnova Ventures | 3.8M | $10M | 0% | Dec 2024 |
|
TCG Crossover Management | 2.2M | $5.9M | 0% | Dec 2024 |
|
Atlas Venture Life Science Advisors | 1.8M | $4.8M | 0% | Dec 2024 |
|
Braidwell | 1.4M | $3.8M | 100% | Dec 2024 |
|
Logos Global Management | 1.4M | $3.7M | 100% | Dec 2024 |
|
Vanguard Group | 1.0M | $2.7M | -13% | Dec 2024 |
|
BlackRock | 975k | $2.6M | 2% | Dec 2024 |
|
ADAR1 Capital Management | 928k | $2.5M | 721% | Dec 2024 |
|
Affinity Asset Advisors | 800k | $2.1M | 33% | Dec 2024 |
|
Morgan Stanley | 787k | $2.4M | 136% | Dec 2024 |
|
Leucadia National Corporation | 600k | $1.6M | 100% | Dec 2024 |
|
Blackstone Group | 500k | $1.3M | 100% | Dec 2024 |
|
Nantahala Capital Management | 483k | $1.3M | 100% | Dec 2024 |
|
State Street Corporation | 375k | $995k | 2% | Dec 2024 |
|
Goldman Sachs Group | 314k | $833k | 95% | Dec 2024 |
|
Geode Capital Management | 295k | $781k | 1% | Dec 2024 |
|
Bank of America Corporation | 231k | $612k | -11% | Dec 2024 |
|
Two Sigma Investments | 226k | $599k | -28% | Dec 2024 |
|
Deltec Asset Management | 194k | $514k | 100% | Dec 2024 |
|
Susquehanna International | 179k | $473k | 92% | Dec 2024 |
|
Two Sigma Advisers | 154k | $407k | 39% | Dec 2024 |
|
Citadel Advisors | 147k | $391k | 198% | Dec 2024 |
|
Group One Trading | 140k | $371k | 1310% | Dec 2024 |
|
Springbok Capital Management | 109k | $290k | 100% | Dec 2024 |
|
Northern Trust | 107k | $283k | 6% | Dec 2024 |
|
Verition Fund Management | 95k | $251k | -5% | Dec 2024 |
|
Acadian Asset Management | 86k | $227k | -76% | Dec 2024 |
|
Vazirani Asset Management | 75k | $199k | 100% | Dec 2024 |
|
Alliancebernstein | 70k | $185k | 0% | Dec 2024 |
|
Jpmorgan Chase & Co | 67k | $178k | 1021% | Dec 2024 |
|
Millennium Management | 66k | $174k | -67% | Dec 2024 |
|
Bridgeway Capital Management | 60k | $159k | 100% | Dec 2024 |
|
Bank Of Montreal | 59k | $157k | 87% | Dec 2024 |
|
Bnp Paribas Arbitrage, Snc | 55k | $145k | 100% | Dec 2024 |
|
Renaissance Technologies | 45k | $118k | 149% | Dec 2024 |
|
Nuveen Asset Management | 40k | $106k | 0% | Dec 2024 |
|
Bank of New York Mellon | 38k | $100k | -9% | Dec 2024 |
|
Scotia Capital | 37k | $99k | 100% | Dec 2024 |
|
CI Private Wealth | 37k | $98k | 100% | Dec 2024 |
|
Charles Schwab Investment Management | 29k | $78k | 0% | Dec 2024 |
|
Harvest Investment Services | 24k | $63k | 100% | Dec 2024 |
|
XTX Topco | 24k | $63k | 100% | Dec 2024 |
|
Rhumbline Advisers | 23k | $57k | 67% | Mar 2025 |
|
Barclays | 21k | $57k | 13% | Dec 2024 |
|
Squarepoint Ops | 20k | $52k | 100% | Dec 2024 |
|
AQR Capital Management | 19k | $50k | -58% | Dec 2024 |
|
Simplex Trading | 19k | $49k | 274% | Dec 2024 |
|
Citigroup | 16k | $43k | -93% | Dec 2024 |
|
Russell Investments | 15k | $40k | 111% | Dec 2024 |
|
Ieq Capital | 14k | $38k | 100% | Dec 2024 |
|
FMR | 14k | $37k | -83% | Dec 2024 |
|
Gts Securities | 10k | $27k | 100% | Dec 2024 |
|
UBS Group | 9.6k | $25k | 51% | Dec 2024 |
|
Federated Investors | 8.5k | $23k | 62% | Dec 2024 |
|
Mirae Asset Global Etfs Holdings | 7.7k | $21k | 4% | Dec 2024 |
|
Wells Fargo & Company | 7.0k | $19k | 44% | Dec 2024 |
|
Corebridge Financial | 6.7k | $18k | 100% | Dec 2024 |
|
New York State Common Retirement Fund | 4.3k | $11k | 0% | Dec 2024 |
|
Tower Research Capital | 3.9k | $10k | -21% | Dec 2024 |
|
CWM | 2.5k | $7.0k | 397% | Dec 2024 |
|
Legal & General Group | 1.1k | $3.0k | 0% | Dec 2024 |
|
California State Teachers Retirement System | 977.00 | $2.6k | 0% | Dec 2024 |
|
NISA Investment Advisors | 868.00 | $2.3k | 334% | Dec 2024 |
|
Summit Investment Advisors | 772.00 | $2.0k | 0% | Dec 2024 |
|
Deutsche Bank Aktiengesellschaft | 720.00 | $1.9k | 4135% | Dec 2024 |
|
Amalgamated Bank | 347.00 | $999.984600 | 0% | Dec 2024 |
|
Royal Bank of Canada | 276.00 | $1.0k | -87% | Dec 2024 |
|
Rothschild Investment | 230.00 | $577.001000 | -2% | Mar 2025 |
|
CoreCap Advisors | 225.00 | $596.002500 | 100% | Dec 2024 |
|
Pnc Financial Services | 168.00 | $444.998400 | 100% | Dec 2024 |
|
SRS Capital Advisors | 117.00 | $310.997700 | 0% | Dec 2024 |
|
Advisor Group Holdings | 112.00 | $297.001600 | 100% | Dec 2024 |
|
Jones Financial Companies, L.L | 100.00 | $265.000000 | 0% | Dec 2024 |
|
Sterling Capital Management | 13.00 | $34.000200 | 0% | Dec 2024 |
|
Capital Advisors | 8.00 | $0 | 0% | Mar 2025 |
|
Who sold out of Aerovate Therapeutics?
Fund or Company Name |
Date Sold |
Shares Held |
Valued At |
---|---|---|---|
Deerfield Management Company | Sep 2024 | 1.4M | $3.0M |
Baker Bros. Advisors | Sep 2024 | 629k | $1.3M |
Eversept Partners | Sep 2024 | 485k | $1.0M |
Octagon Capital Advisors | Sep 2024 | 465k | $973k |
Opaleye Management | Sep 2024 | 440k | $920k |
GSA Capital Partners | Sep 2024 | 414k | $865k |
Ikarian Capital | Sep 2024 | 368k | $769k |
Boothbay Fund Management | Sep 2024 | 98k | $205k |
FNY Investment Advisers | Dec 2024 | 75k | $198k |
Ing Investment Management | Sep 2024 | 66k | $137k |
Nan Fung Group Holdings | Sep 2024 | 48k | $100k |
State of Wisconsin Investment Board | Sep 2024 | 29k | $61k |
ExodusPoint Capital Management | Sep 2024 | 21k | $44k |
Jane Street | Sep 2024 | 18k | $37k |
Dimensional Fund Advisors | Sep 2024 | 11k | $22k |
Balyasny Asset Management | Sep 2024 | 10k | $21k |
Corsair Capital Management | Sep 2024 | 10k | $21k |
Virtus ETF Advisers | Sep 2024 | 3.7k | $7.8k |
Efficient Wealth Management | Sep 2024 | 258.00 | $0 |
Capital Performance Advisors | Sep 2024 | 80.00 | $167.000000 |